GORE ENFORM Intraperitoneal Biomaterial: payments to doctors
Payments that named GORE ENFORM Intraperitoneal Biomaterial as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $156K
- Providers
- 87
- Transactions
- 225
- Average per transaction
- $691
The per-transaction average — $691 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 87 providers the average total is $1,788, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| W. L. Gore & Associates, Inc. | $155,513 | 100.0% |